<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">endoserg</journal-id><journal-title-group><journal-title xml:lang="ru">Эндокринная хирургия</journal-title><trans-title-group xml:lang="en"><trans-title>Endocrine Surgery</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2306-3513</issn><issn pub-type="epub">2310-3965</issn><publisher><publisher-name>Типография «Печатных дел Мастер»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/2306-3513-2008-2-6-20</article-id><article-id custom-type="elpub" pub-id-type="custom">endoserg-4016</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>Первичный гиперальдостеронизм. Клинические рекомендации</article-title><trans-title-group xml:lang="en"><trans-title>Pervichnyy giperal'dosteronizm. Klinicheskie rekomendatsii</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="western" xml:lang="en"><surname>Bel'tsevich</surname><given-names>D G</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>15</day><month>06</month><year>2008</year></pub-date><volume>2</volume><issue>2</issue><issue-title>№2 (2008)</issue-title><fpage>6</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Bel'tsevich D.G., 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder xml:lang="ru">Bel'tsevich D.G.</copyright-holder><copyright-holder xml:lang="en">Bel'tsevich D.G.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.surg-endojournals.ru/jour/article/view/4016">https://www.surg-endojournals.ru/jour/article/view/4016</self-uri><abstract><p>Расширенный реферат по материалам J Clin Endocrin Metab. June 13. 2008</p></abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Atkins D, Best D, Briss PA. Eccles M. Falck-Yiter Y, Flottorp S, Guyall GH. Harbour RT, Haugh MC. Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N. Mason J. Middleton P, Mrukowiez J. O'Connell D, Oxman AD, i’hiliips B, Schunemann HJ. EdejerTT, Varonen H, Vist GE, Williams JW, Jr., Zaza S 2004 Grading quality of evidence and strength of recommendations. BMJ 328:1490</mixed-citation><mixed-citation xml:lang="en">Atkins D, Best D, Briss PA. Eccles M. Falck-Yiter Y, Flottorp S, Guyall GH. Harbour RT, Haugh MC. Henry D, Hill S, Jaeschke R, Leng G, Liberati A, Magrini N. Mason J. Middleton P, Mrukowiez J. O'Connell D, Oxman AD, i’hiliips B, Schunemann HJ. EdejerTT, Varonen H, Vist GE, Williams JW, Jr., Zaza S 2004 Grading quality of evidence and strength of recommendations. BMJ 328:1490</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Swiglo BA, Murad M11, Schunemann HJ, Kunz R, Vigersky RA. Guyatt GH, Moutori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666-73</mixed-citation><mixed-citation xml:lang="en">Swiglo BA, Murad M11, Schunemann HJ, Kunz R, Vigersky RA. Guyatt GH, Moutori VM 2008 A case for clarity, consistency, and helpfulness: state-of-the-art clinical practice guidelines in endocrinology using the grading of recommendations, assessment, development, and evaluation system. J Clin Endocrinol Metab 93:666-73</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PF. 1988 The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum H ypertens 2:187-9</mixed-citation><mixed-citation xml:lang="en">Andersen GS, Toftdahl DB, Lund JO, Strandgaard S, Nielsen PF. 1988 The incidence rate of phaeochromocytoma and Conn's syndrome in Denmark, 1977-1981. J Hum H ypertens 2:187-9</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Berglund G, Andersson O, Wilhelmsen L 1976 Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J 2:554-6</mixed-citation><mixed-citation xml:lang="en">Berglund G, Andersson O, Wilhelmsen L 1976 Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J 2:554-6</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Fishman LM. Kuchcl O, Liddle GW. Michelakis AM. Gordon RD. Chick WT 1968 Incidence ofprimary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA 205:497502</mixed-citation><mixed-citation xml:lang="en">Fishman LM. Kuchcl O, Liddle GW. Michelakis AM. Gordon RD. Chick WT 1968 Incidence ofprimary aldosteronism uncomplicated "essential" hypertension. A prospective study with elevated aldosterone secretion and suppressed plasma renin activity used as diagnostic criteria. JAMA 205:497502</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Kaplan NM 1967 Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med 66:1079-90</mixed-citation><mixed-citation xml:lang="en">Kaplan NM 1967 Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism. Ann Intern Med 66:1079-90</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Streeten DH, Tomycz N, Anderson GH 1979 Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 67:403-13</mixed-citation><mixed-citation xml:lang="en">Streeten DH, Tomycz N, Anderson GH 1979 Reliability of screening methods for the diagnosis of primary aldosteronism. Am J Med 67:403-13</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Tucker RM, Labarthe DR 1977 Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin Proc 52:549-5</mixed-citation><mixed-citation xml:lang="en">Tucker RM, Labarthe DR 1977 Frequency of surgical treatment for hypertension in adults at the Mayo Clinic from 1973 through 1975. Mayo Clin Proc 52:549-5</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD. Robertson JW 1987 Secondary hypertension in a blood pressure clinic. Arch Intern Med 147:1289-93</mixed-citation><mixed-citation xml:lang="en">Sinclair AM, Isles CG, Brown I, Cameron H, Murray GD. Robertson JW 1987 Secondary hypertension in a blood pressure clinic. Arch Intern Med 147:1289-93</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Fardclla CE, Mosso L, Gomez-Satichez C, Cortes P. Soto J, Gomez L, Pinto M, Huete A. Ocstrcicher E, Foradori A, Montero.1 2000 Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85:1863-7</mixed-citation><mixed-citation xml:lang="en">Fardclla CE, Mosso L, Gomez-Satichez C, Cortes P. Soto J, Gomez L, Pinto M, Huete A. Ocstrcicher E, Foradori A, Montero.1 2000 Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology. J Clin Endocrinol Metab 85:1863-7</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon RD, Slowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-8</mixed-citation><mixed-citation xml:lang="en">Gordon RD, Slowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-8</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Grim CE, Weinberger MH, Higgins JT. Kramer NJ 1977 Diagnosis of secondary forms of hypertension, A comprehensive protocol. JAMA 237:1331-5</mixed-citation><mixed-citation xml:lang="en">Grim CE, Weinberger MH, Higgins JT. Kramer NJ 1977 Diagnosis of secondary forms of hypertension, A comprehensive protocol. JAMA 237:1331-5</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Hamlet SM, Tunny TJ, Woodland E, Gordon RD 1985 Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?Clin Exp Pharmacol Physiol 12:249-52</mixed-citation><mixed-citation xml:lang="en">Hamlet SM, Tunny TJ, Woodland E, Gordon RD 1985 Is aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism?Clin Exp Pharmacol Physiol 12:249-52</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Lim PO, Dow E, Brennan G, Jung RT, MacDonald 'ГМ 2000 High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum 1-Iypertens 14:311 -5</mixed-citation><mixed-citation xml:lang="en">Lim PO, Dow E, Brennan G, Jung RT, MacDonald 'ГМ 2000 High prevalence of primary aldosteronism in the Tayside hypertension clinic population. J Hum 1-Iypertens 14:311 -5</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Loh КС. Koay ES, Khaw MC, Emmanuel SC, Young WF, Jr. 2000 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-9</mixed-citation><mixed-citation xml:lang="en">Loh КС. Koay ES, Khaw MC, Emmanuel SC, Young WF, Jr. 2000 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-9</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Mosso L. Carvajal C. Gonzalez A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE 2003 Primary aldosteronism and hypertensive disease. Hypertension 42:161 -5</mixed-citation><mixed-citation xml:lang="en">Mosso L. Carvajal C. Gonzalez A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE 2003 Primary aldosteronism and hypertensive disease. Hypertension 42:161 -5</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello M.I, Moretti A. Palumbo G, Parenti G, Porteri E. Semplicini A. Rizzoni D, Rossi E, Boscaro M. Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-300</mixed-citation><mixed-citation xml:lang="en">Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello M.I, Moretti A. Palumbo G, Parenti G, Porteri E. Semplicini A. Rizzoni D, Rossi E, Boscaro M. Pessina AC, Mantero F 2006 A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 48:2293-300</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz GL, Turner ST 2005 Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. ClinChem 51:386-94</mixed-citation><mixed-citation xml:lang="en">Schwartz GL, Turner ST 2005 Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity. ClinChem 51:386-94</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Mulatero P, Stowasser M, Loh КС, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF, Jr. 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-50</mixed-citation><mixed-citation xml:lang="en">Mulatero P, Stowasser M, Loh КС, Fardella CE, Gordon RD, Mosso L, Gomez-Sanchez CE, Veglio F, Young WF, Jr. 2004 Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J Clin Endocrinol Metab 89:1045-50</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi GP, Bernini G. Desideri G, Fabris B. Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M. Matterello MJ. Montemurro D, Palumbo G, Rizzoni D, Rossi E. Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results ofthe PAPY Study. Hypertension48:232-8</mixed-citation><mixed-citation xml:lang="en">Rossi GP, Bernini G. Desideri G, Fabris B. Ferri C, Giacchetti G, Letizia C, Maccario M, Mannelli M. Matterello MJ. Montemurro D, Palumbo G, Rizzoni D, Rossi E. Pessina AC, Mantero F 2006 Renal damage in primary aldosteronism: results ofthe PAPY Study. Hypertension48:232-8</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Millicz P. Girerd X. Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-8</mixed-citation><mixed-citation xml:lang="en">Millicz P. Girerd X. Plouin PF, Blacher J, Safar ME, Mourad JJ 2005 Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 45:1243-8</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Stowasser M, Shatman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH 2005 Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90:5070-6</mixed-citation><mixed-citation xml:lang="en">Stowasser M, Shatman J, Leano R, Gordon RD, Ward G, Cowley D, Marwick TH 2005 Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I. J Clin Endocrinol Metab 90:5070-6</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F2002 High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15:896-902</mixed-citation><mixed-citation xml:lang="en">Rossi E, Regolisti G, Negro A, Sani C, Davoli S, Perazzoli F2002 High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives. Am J Hypertens 15:896-902</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Strauch B, Zelinka T, Hampf M, Bernhardt R. Widimsky J, Jr. 2003 Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 17:349-52</mixed-citation><mixed-citation xml:lang="en">Strauch B, Zelinka T, Hampf M, Bernhardt R. Widimsky J, Jr. 2003 Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 17:349-52</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Williams JS. Williams GH, Raji A. Jeunemaitre X, Brown NJ. Hopkins PN, C'onlin PR 2006 Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum I lypertens 20:129-36</mixed-citation><mixed-citation xml:lang="en">Williams JS. Williams GH, Raji A. Jeunemaitre X, Brown NJ. Hopkins PN, C'onlin PR 2006 Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum I lypertens 20:129-36</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Benchetrit S, Bemhcim J, Podjarny E 2002 Normokalemic hyperaldosteronism in patients with resistant hypertension. ]sr Med Assoc.1 4:17-20</mixed-citation><mixed-citation xml:lang="en">Benchetrit S, Bemhcim J, Podjarny E 2002 Normokalemic hyperaldosteronism in patients with resistant hypertension. ]sr Med Assoc.1 4:17-20</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Wcissmann P 2002 Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40:892-6</mixed-citation><mixed-citation xml:lang="en">Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Wcissmann P 2002 Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40:892-6</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Eide IK.Torjesen PA, Drolsum A,BabovicA, Lillcdahl NP2004 Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 22:2217-26</mixed-citation><mixed-citation xml:lang="en">Eide IK.Torjesen PA, Drolsum A,BabovicA, Lillcdahl NP2004 Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 22:2217-26</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Gallay B.I. Ahmad S, Xu L, Toivola B, Davidson RC 2001 Screening for primary aldosteronism without discontinuing hypertensive medications: plasmaaldosterone-renin ratio. Am J Kidney Dis 37:699-705</mixed-citation><mixed-citation xml:lang="en">Gallay B.I. Ahmad S, Xu L, Toivola B, Davidson RC 2001 Screening for primary aldosteronism without discontinuing hypertensive medications: plasmaaldosterone-renin ratio. Am J Kidney Dis 37:699-705</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Goodfriend TL, Calhoun DA 2004 Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43:518-24</mixed-citation><mixed-citation xml:lang="en">Goodfriend TL, Calhoun DA 2004 Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy. Hypertension 43:518-24</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Calhoun DA, Nishizaka MK, Zaman MA, Harding SM 2004 Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125:112-7</mixed-citation><mixed-citation xml:lang="en">Calhoun DA, Nishizaka MK, Zaman MA, Harding SM 2004 Aldosterone excretion among subjects with resistant hypertension and symptoms of sleep apnea. Chest 125:112-7</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Aso Y, Homma Y 1992 A survey on incidental adrenal tumors in Japan. J Urol 147:1478-81</mixed-citation><mixed-citation xml:lang="en">Aso Y, Homma Y 1992 A survey on incidental adrenal tumors in Japan. J Urol 147:1478-81</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Barzon L, Sonino N, Fallo F. Palu G. Boscaro M 2003 Prevalence and natural history of adrenal incidentalomas. EurJ Endocrinol 149:273-85</mixed-citation><mixed-citation xml:lang="en">Barzon L, Sonino N, Fallo F. Palu G. Boscaro M 2003 Prevalence and natural history of adrenal incidentalomas. EurJ Endocrinol 149:273-85</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Bulow B, Ahren В 2002 Adrenal incidentaloma—experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252:239-46</mixed-citation><mixed-citation xml:lang="en">Bulow B, Ahren В 2002 Adrenal incidentaloma—experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med 252:239-46</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Caplan RH, Strutt PJ. Wickus GG 1994 Subclinical hormone secretion by incidentallydiscoveredadrenal masses. Arch Surg 129:291 -6</mixed-citation><mixed-citation xml:lang="en">Caplan RH, Strutt PJ. Wickus GG 1994 Subclinical hormone secretion by incidentallydiscoveredadrenal masses. Arch Surg 129:291 -6</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Kim HY. Kim SG, Lee KW, Seo JA. Kim NH, Choi KM, Baik SH, Choi DS 2005 Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 20:303-9</mixed-citation><mixed-citation xml:lang="en">Kim HY. Kim SG, Lee KW, Seo JA. Kim NH, Choi KM, Baik SH, Choi DS 2005 Clinical study of adrenal incidentaloma in Korea. Korean J Intern Med 20:303-9</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Mantero F, Terzolo M. Amaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opochcr G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-44</mixed-citation><mixed-citation xml:lang="en">Mantero F, Terzolo M. Amaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opochcr G, Angeli A 2000 A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637-44</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Rossi GP, Sacchetto A, Viscntin P, Canali C, Graniero GR, Palatini P, Pessina AC 1996 Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27:1039-45</mixed-citation><mixed-citation xml:lang="en">Rossi GP, Sacchetto A, Viscntin P, Canali C, Graniero GR, Palatini P, Pessina AC 1996 Changes in left ventricular anatomy and function in hypertension and primary aldosteronism. Hypertension 27:1039-45</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Montori VM, Young WF, Jr. 2002 Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 31:619-32, xi</mixed-citation><mixed-citation xml:lang="en">Montori VM, Young WF, Jr. 2002 Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 31:619-32, xi</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H. Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589-93</mixed-citation><mixed-citation xml:lang="en">Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H. Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients. Arch Intern Med 141:1589-93</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">McKenna TJ, Sequeira SJ, Heffeman A, Chambers J, Cunningham S 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73:952-7</mixed-citation><mixed-citation xml:lang="en">McKenna TJ, Sequeira SJ, Heffeman A, Chambers J, Cunningham S 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab 73:952-7</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM 2003 High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 21:2149-57</mixed-citation><mixed-citation xml:lang="en">Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, Smithers BM 2003 High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients. J Hypertens 21:2149-57</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Gordon RD 1995 Primary aldosteronism. J Endocrinol Invest 18:495511</mixed-citation><mixed-citation xml:lang="en">Gordon RD 1995 Primary aldosteronism. J Endocrinol Invest 18:495511</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
